Considering that the therapeutic effect of RAI ultimately depends on the expression of NIS on the plasma membrane of thyroid cancer cells, we extracted cell membrane proteins and cytoplasmic proteins to study the expression of NIS in thyroid cancer cells. This evidence concerns the gene SLC5A5 and thyroid gland carcinoma.